17 alpha-hydroxyprogesterone (Gestiva, Adeza) for the prevention of preterm labor
Approvable designation
Fast-track designations
Orphan drug designations
Drugs to Watch: Mental Health Conditions
April 11th 2024The FDA is reviewing two novel therapies: a psychedelic-assisted therapy for PTSD with a target action date of Aug. 11, 2024, and therapy for schizophrenia that does not directly block dopamine receptors with an action date of Sept. 26, 2024.